{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:24:11Z","timestamp":1777983851125,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100031514","name":"Health Commission of Chengdu Municipality","doi-asserted-by":"crossref","award":["2024173"],"award-info":[{"award-number":["2024173"]}],"id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100031514","name":"Health Commission of Chengdu Municipality","doi-asserted-by":"crossref","award":["2024173"],"award-info":[{"award-number":["2024173"]}],"id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100031514","name":"Health Commission of Chengdu Municipality","doi-asserted-by":"crossref","award":["2024173"],"award-info":[{"award-number":["2024173"]}],"id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100031514","name":"Health Commission of Chengdu Municipality","doi-asserted-by":"crossref","award":["2024173"],"award-info":[{"award-number":["2024173"]}],"id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100031514","name":"Health Commission of Chengdu Municipality","doi-asserted-by":"crossref","award":["2024173"],"award-info":[{"award-number":["2024173"]}],"id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100031514","name":"Health Commission of Chengdu Municipality","doi-asserted-by":"crossref","award":["2024173"],"award-info":[{"award-number":["2024173"]}],"id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100031514","name":"Health Commission of Chengdu Municipality","doi-asserted-by":"crossref","award":["2024173"],"award-info":[{"award-number":["2024173"]}],"id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41506-2","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:24:35Z","timestamp":1772526275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The diagnostic value of CDC20 for malignant pleural effusion of lung adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Yulan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanghua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"1","key":"41506_CR1","first-page":"7","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66 (1), 7\u201330 (2016).","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"41506_CR2","doi-asserted-by":"publisher","first-page":"a037895","DOI":"10.1101\/cshperspect.a037895","volume":"12","author":"T Cascone","year":"2022","unstructured":"Cascone, T. et al. Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer. Cold Spring Harb Perspect. Med. 12 (5), a037895 (2022).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"1","key":"41506_CR3","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1186\/s12885-019-6101-7","volume":"19","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies. BMC Cancer. 19 (1), 886 (2019).","journal-title":"BMC Cancer"},{"issue":"8","key":"41506_CR4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/carcin\/bgz190","volume":"41","author":"I Giopanou","year":"2020","unstructured":"Giopanou, I. et al. Osteopontin drives KRAS-mutant lung adenocarcinoma. Carcinogenesis 41 (8), 1134\u20131144 (2020).","journal-title":"Carcinogenesis"},{"key":"41506_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/CMAR.S232383","volume":"12","author":"Q Wu","year":"2020","unstructured":"Wu, Q. et al. Combination of Serum miRNAs with Serum Exosomal miRNAs in Early Diagnosis for Non-Small-Cell Lung Cancer. Cancer Manag Res. 12, 485\u2013495 (2020).","journal-title":"Cancer Manag Res."},{"issue":"4","key":"41506_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.chest.2016.11.010","volume":"151","author":"N Taghizadeh","year":"2017","unstructured":"Taghizadeh, N., Fortin, M. & Tremblay, A. US Hospitalizations for Malignant Pleural Effusions: Data From the 2012 National Inpatient Sample. Chest 151 (4), 845\u2013854 (2017).","journal-title":"Chest"},{"issue":"3","key":"41506_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1378\/chest.08-2968","volume":"136","author":"WN William Jr","year":"2009","unstructured":"William, W. N. Jr et al. Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data. Chest 136 (3), 701\u2013709 (2009).","journal-title":"Chest"},{"issue":"1","key":"41506_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12890-017-0526-z","volume":"17","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. The pleural fluid lactate dehydrogenase\/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions. BMC Pulm Med. 17 (1), 168 (2017).","journal-title":"BMC Pulm Med."},{"issue":"13\u201314","key":"41506_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.clinbiochem.2010.05.016","volume":"43","author":"JS Hackbarth","year":"2010","unstructured":"Hackbarth, J. S. et al. Performance of CEA and CA19-9 in identifying pleural effusions caused by specific malignancies. Clin. Biochem. 43 (13\u201314), 1051\u20131055 (2010).","journal-title":"Clin. Biochem."},{"issue":"6","key":"41506_CR10","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1378\/chest.126.6.1757","volume":"126","author":"JM Porcel","year":"2004","unstructured":"Porcel, J. M. et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15\u2009\u2013\u20093, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 126 (6), 1757\u20131763 (2004).","journal-title":"Chest"},{"issue":"3","key":"41506_CR11","doi-asserted-by":"publisher","first-page":"e23091","DOI":"10.1002\/jcla.23091","volume":"34","author":"F Zhang","year":"2020","unstructured":"Zhang, F. et al. Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion. J. Clin. Lab. Anal. 34 (3), e23091 (2020).","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"41506_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.lungcan.2013.09.016","volume":"82","author":"J Creaney","year":"2013","unstructured":"Creaney, J. et al. Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma. Lung Cancer. 82 (3), 491\u2013498 (2013).","journal-title":"Lung Cancer"},{"issue":"4","key":"41506_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.currproblcancer.2018.10.001","volume":"43","author":"S Javath Hussain","year":"2019","unstructured":"Javath Hussain, S. et al. Clinical utility of pleural fluid YKL-40 as a marker of malignant pleural effusion. Curr. Probl. Cancer. 43 (4), 354\u2013362 (2019).","journal-title":"Curr. Probl. Cancer"},{"issue":"6","key":"41506_CR14","doi-asserted-by":"publisher","first-page":"e22901","DOI":"10.1002\/jcla.22901","volume":"33","author":"T Tian","year":"2019","unstructured":"Tian, T. et al. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion. J. Clin. Lab. Anal. 33 (6), e22901 (2019).","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"41506_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12885-020-07327-w","volume":"20","author":"H Choi","year":"2020","unstructured":"Choi, H., Ko, Y. & Lee, C. Y. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study. BMC Cancer. 20 (1), 825 (2020).","journal-title":"BMC Cancer"},{"issue":"1","key":"41506_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12885-020-06851-z","volume":"20","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples. BMC Cancer. 20 (1), 344 (2020).","journal-title":"BMC Cancer"},{"issue":"2","key":"41506_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5858\/arpa.2011-0320-OA","volume":"136","author":"BM Turner","year":"2012","unstructured":"Turner, B. M. et al. A new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Arch. Pathol. Lab. Med. 136 (2), 163\u2013171 (2012).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"5","key":"41506_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/resp.12543","volume":"20","author":"JM Porcel","year":"2015","unstructured":"Porcel, J. M. et al. TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions. Respirology 20 (5), 831\u2013833 (2015).","journal-title":"Respirology"},{"issue":"2","key":"41506_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cncy.20135","volume":"119","author":"N Fatima","year":"2011","unstructured":"Fatima, N. et al. .TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Cancer Cytopathol. 119 (2), 127\u2013133 (2011).","journal-title":"Cancer Cytopathol."},{"issue":"2","key":"41506_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/nu9020109","volume":"9","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Inhibition of Cell Survival by Curcumin Is Associated with Downregulation of Cell Division Cycle 20 (Cdc20) in Pancreatic Cancer Cells. Nutrients 9 (2), 109 (2017).","journal-title":"Nutrients"},{"issue":"11","key":"41506_CR21","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1021\/acs.biomac.8b00918","volume":"19","author":"MB Parmar","year":"2018","unstructured":"Parmar, M. B. et al. Additive Polyplexes to Undertake siRNA Therapy against CDC20 and Survivin in Breast Cancer Cells. Biomacromolecules 19 (11), 4193\u20134206 (2018).","journal-title":"Biomacromolecules"},{"issue":"4","key":"41506_CR22","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3892\/ijo.2016.3671","volume":"49","author":"K Li","year":"2016","unstructured":"Li, K. et al. Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel. Int. J. Oncol. 49 (4), 1679\u20131685 (2016).","journal-title":"Int. J. Oncol."},{"issue":"1","key":"41506_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12957-020-01817-8","volume":"18","author":"J Li","year":"2020","unstructured":"Li, J. et al. .CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis. World J. Surg. Oncol. 18 (1), 50 (2020).","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"41506_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3892\/mmr.2021.12122","volume":"24","author":"G Yang","year":"2021","unstructured":"Yang, G. et al. .CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition. Mol. Med. Rep. 24 (1), 483 (2021).","journal-title":"Mol. Med. Rep."},{"issue":"14","key":"41506_CR25","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1073\/pnas.1814060116","volume":"116","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma. Proc. Natl. Acad. Sci. USA. 116 (14), 6975\u20136984 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"41506_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pharmthera.2015.04.002","volume":"151","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol. Ther. 151, 141\u2013151 (2015).","journal-title":"Pharmacol. Ther."},{"key":"41506_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.canlet.2020.11.052","volume":"500","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation. Cancer Lett. 500, 172\u2013181 (2021).","journal-title":"Cancer Lett."},{"issue":"15","key":"41506_CR28","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/ijms20153705","volume":"20","author":"ZH Chen","year":"2019","unstructured":"Chen, Z. H. et al. ESRP1 Induces Cervical Cancer Cell G1-Phase Arrest Via Regulating Cyclin A2 mRNA Stability. Int. J. Mol. Sci. 20 (15), 3705 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"41506_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12672-024-01109-7","volume":"15","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Diagnostic value of immune-related biomarker FAM83A in differentiating malignant from benign pleural effusion in lung adenocarcinoma. Discov Oncol. 15 (1), 242 (2024).","journal-title":"Discov Oncol."},{"issue":"1","key":"41506_CR30","doi-asserted-by":"publisher","first-page":"10489","DOI":"10.1038\/s41598-022-14331-6","volume":"12","author":"M Cuadrado","year":"2022","unstructured":"Cuadrado, M. et al. Efficient terminal erythroid differentiation requires the APC\/C cofactor Cdh1 to limit replicative stress in erythroblasts. Sci. Rep. 12 (1), 10489 (2022).","journal-title":"Sci. Rep."},{"issue":"5","key":"41506_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4196\/kjpp.2023.27.5.427","volume":"27","author":"JH Kim","year":"2023","unstructured":"Kim, J. H. & Patel, R. Mad2B forms a complex with Cdc20, Cdc27, Rev3 and Rev1 in response to cisplatin-induced DNA damage. Korean J. Physiol. Pharmacol. 27 (5), 427\u2013436 (2023).","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"2","key":"41506_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","volume":"6","author":"WD Travis","year":"2011","unstructured":"Travis, W. D. et al. International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 6 (2), 244\u2013285 (2011).","journal-title":"J. Thorac. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41506-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T22:02:04Z","timestamp":1775772124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41506-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41506"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41506-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7066819\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study protocol related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the Ethics Committee of the Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital.Informed Consent for Publication: Informed consent was obtained from all individual participants included in the study for the publication of any potentially identifiable data or images presented in this manuscript. The consent forms are held by the authors and are available for review by the Editor-in-Chief if requested.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"11786"}}